Related Experiment Video

Updated: Jun 29, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

The transcription factor ETS-1: its role in tumour development and strategies for its inhibition

Jens Claus Hahne1, Ali Fuat Okuducu, Aygün Sahin

  • 1Institute of Pathology, University of Bonn, P.O. Box 2120, 53011 Bonn, Germany.

Mini Reviews in Medicinal Chemistry
|October 16, 2008
PubMed

Insights

Transcription factors regulate gene expression and are key in cancer. This review highlights Ets-1

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Transcription factors regulate gene expression, impacting cellular processes.
  • Aberrant transcription factor activity is implicated in various cancers.
  • The ETS family, particularly Ets-1, plays roles in cell development and cancer progression.

Purpose of the Study:

  • To review the role of Ets-1 in tumor development and progression.
  • To emphasize Ets-1's involvement in tumor vascularization and invasion.
  • To discuss Ets-1 inhibition as a cancer therapy strategy.

Main Methods:

  • Literature review focusing on Ets-1 function in cancer.
  • Analysis of Ets-1's role in gene transactivation related to cancer.
  • Examination of Ets-1's impact on tumor angiogenesis and metastasis.

Main Results:

  • Ets-1 is a critical transcription factor in tumor development and progression.
  • Ets-1 influences tumor vascularization and invasion.
  • Deregulation of ETS genes can lead to malignant transformation.

Conclusions:

  • Ets-1 is a significant factor in tumor progression, including invasion and angiogenesis.
  • Targeting Ets-1 offers a potential strategy for cancer therapy.
  • Understanding Ets-1's molecular mechanisms is crucial for developing novel treatments.

More Related Videos

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...